| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.02 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |